MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Multicenter, randomized, placebo-controlled, double-blind, parallel-group proof-of-concept study of lixisenatide in patients with early Parkinson’s disease (PD): the LIXIPARK trial (NCT03439943)

    WG. Meissner, P. Remy, C. Giordana, D. Maltete, P. Damier, JL. Houeto, C. Geny, L. Hopes, F. Durif, G. Defer, C. Tranchant, JC. Corvol, N. Carriere, JP. Azulay, S. Drapier, P. Krystkowiak, C. Thalamas, A. Benard, O. Rascol, N. Ns-Park/fcrin (Bordeaux, France)

    Objective: To evaluate the “disease-modifying” effect of lixisenatide as adjunct to antiparkinsonian medications in patients with early PD. Background: Lixisenatide, a glucagon-like peptide 1 receptor…
  • 2023 International Congress

    Stability of basal ganglia beta band power distribution during continuous deep brain stimulation in Parkinson’s disease: analysis of sub-cohort from the ADAPT-PD trial

    L. Hammer, E. Yilmaz, S. Little, H. Zahed, M. Volz, S. Ravi, S. Wang, P. Starr, J. Ostrem (San Francisco, USA)

    Objective: To assess the stability of the daily distribution of peak subthalamic nucleus (STN) and globus pallidus internus (GPi) beta band power during continuous deep…
  • 2023 International Congress

    Evaluation of Cognitive Assessment Tools in Parkinson’s Disease

    L. Cao, Y. Huang (Beijing, China)

    Objective: To evaluate a variety of cognitive assessment scales in a longitudinal Parkinson’s disease (PD) cohort. Background: Cognitive impairment is one of the most common and…
  • 2023 International Congress

    Chronic pain and the polytrauma clinical triad are risk factors for prodromal PD

    L. Neilson, N. Balba, J. Elliott, G. Scott, M. Heinricher, M. Lim (Portland, USA)

    Objective: This study aimed to assess whether chronic pain is a risk factor for prodromal Parkinson disease and determine if pain severity and comorbidity with…
  • 2023 International Congress

    Sensitivity, consistency and test-retest reliability of home-based freezing of gait-provoking tests in people with Parkinson’s disease

    D. Zoetewei, P. Ginis, M. Gilat, T. Herman, M. Brozgol, P. Thumm, J. Hausdorff, A. Nieuwboer, N. D'Cruz (Leuven, Belgium)

    Objective: To evaluate the sensitivity, consistency and test-retest reliability of several freezing of gait (FOG)-provoking tests in the homes of people with Parkinson’s disease (PD)…
  • 2023 International Congress

    A Case of Post-malaria neurological syndrome presenting with tremor

    JS. Lee, JH. Ahn, JY. Youn, JH. Cho (Seoul, Republic of Korea)

    Objective: We report a case of post-malaria neurological syndrome (PMNS) presenting with tremor in a Korean patient. Background: PMNS is a rare neurological complication which…
  • 2023 International Congress

    Effects of GBA1 mutations and STN-DBS on response inhibition in Parkinson’s disease

    A. Almelegy, S. Gunda, S. Buyske, M. Rosenbaum, S. Sani, M. Afshari, L. Metman, C. Goetz, D. Hall, M. Mouradian, G. Pal (New Brunswick, USA)

    Objective: To determine specific pattern of cognitive dysfunction in Parkinson’s disease (PD) patients who are glucocerebrosidase mutation carriers (PD-GBA1) compared with non-mutation carriers with and…
  • 2023 International Congress

    Parkinsonism and dilated ventricles: not all hydrocephalus is normal-pressure

    D. Tang, J. Vijayan, CH. Tan, SF. Woo, JH. Tan (Singapore, Singapore)

    Objective: We discuss a patient with rapidly progressive parkinsonism with radiological features of normal pressure hydrocephalus, who was diagnosed with obstructive hydrocephalus secondary to intracranial…
  • 2023 International Congress

    The Effects of Consecutive and Integrated Postural-Cognitive Training on Dual-task Walking in Parkinson’s Disease with Mild Cognitive Impairment: EEG Relative Power and Clinical Implication

    YA. Chen, CY. Huang, RM. Wu, CL. Chang (Taipei, Taiwan)

    Objective: The purpose of this study was to compare the effects of consecutive and integrated postural-cognitive training on dual-task walking performance and its related cortical…
  • 2023 International Congress

    Ethnic and Gender Disparities in Access to Deep Brain Stimulation for Parkinson’s Disease Among Participants in C-OPN

    I. Ojo, S. Poonja, J. Miyasaki, A. Shetty, T. Sankar, F. Ba (Edmonton, Canada)

    Objective: To study the disparities in gender and ethnicity and the related contributing factors in Parkinson’s disease (PD) patients who require deep brain stimulation (DBS),…
  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley